My da|ra Login

Detailed view

metadata language: English

Identifying Extensions of Protection in Prescription Drugs: Navigating the Data Landscape for Large-Scale Analysis

Version
2
Resource Type
Dataset : administrative records data
Creator
  • Feldman, Robin (The University of California, Hastings College of the Law)
Publication Date
2018-01-03
Funding Reference
  • Laura and John Arnold Foundation
    • Award Number: 000004624
Free Keywords
Pharmaceuticals; Patent and Exclusivities; FDA; Drug; Patent
Description
  • Abstract

    Patents and exclusivities have become an increasingly important component in the “life cycle management” strategies that are employed by pharmaceutical companies to prolong the period of market monopoly for their drugs.

    Presenting the first comprehensive study of evergreening, this study examines all pharmaceuticals in the U.S. the market between 2005 and 2015, collecting 160,000 data points to note every instance in which a company added a new patent or exclusivity. This study gathers patent and exclusivity information published in the “Orange Book,” which is a regular FDA publication containing information on approved drugs, their therapeutically equivalent generics, and the patents and exclusivities attached to approved drugs, among other drug-related data.
Temporal Coverage
  • 2005-01-01 / 2015-12-31
    Time Period: Sat Jan 01 00:00:00 EST 2005--Thu Dec 31 00:00:00 EST 2015
Availability
Download

Update Metadata: 2018-12-19 | Issue Number: 1 | Registration Date: 2018-12-19

Feldman, Robin (2018): Identifying Extensions of Protection in Prescription Drugs: Navigating the Data Landscape for Large-Scale Analysis. Version: 2. ICPSR - Interuniversity Consortium for Political and Social Research. Dataset. https://doi.org/10.3886/E104781V2